LMR Partners’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

LMR Partners’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,024,279	Closed	-$9.98M	–	1085
2023 Q2	$9.98M	Buy	4,024,279 +276,442	+7%	+$544K	0.11%	188
2023 Q1	$27.7M	Buy	3,747,837 +600	+0%	+$1.11K	0.43%	61
2022 Q4	$29.9M	Buy	3,747,237 +300,000	+9%	+$329K	0.52%	36
2022 Q3	$11.1M	Hold	3,447,237	–	–	0.2%	112
2022 Q2	$14M	Buy	3,447,237 +450,123	+15%	+$236K	0.24%	95
2022 Q1	$14.8M	Buy	2,997,114 +51,800	+2%	+$65.8K	0.17%	125
2021 Q4	$29.7M	Buy	+2,945,314	New	+$4.5M	0.3%	60

LMR Partners's ROIVW Position: Q3 2023 in Review

LMR Partners sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 4,024,279 shares — an estimated $9.98M sold.

LMR Partners first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $29.9M in Q4 2022. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

LMR Partners reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
LMR Partners sold 4,024,279 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $9.98M.
LMR Partners first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
LMR Partners's Roivant Sciences Ltd. Warrant position peaked at $29.9M in Q4 2022.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.